Skip to main content
Erschienen in: Cancer Causes & Control 3/2006

01.04.2006 | Original Paper

Decline in Cervical Cancer Incidence and Mortality in New South Wales in Relation to Control Activities (Australia)

verfasst von: Richard Taylor, Stephen Morrell, Hassan Mamoon, Gerard Wain, Jayne Ross

Erschienen in: Cancer Causes & Control | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

To examine time trends in cervical cancer incidence and mortality in NSW women aged ¥20 years in relation to important health service initiatives and programs.

Methods

Data on cervical cancer incidence and mortality were obtained from the NSW Central Cancer Registry for 1972–2001, and corresponding annual populations obtained from the Australian Bureau of Statistics. Direct age-standardised rates in the ¥20 year population were calculated using the 2001 NSW census population as standard. Proportional reductions in incidence and mortality since 1972–1974 were also calculated and related to key health service factors and to published NSW 5-year cervical cancer relative survival for similar periods.

Results

Declines in cervical cancer incidence (−10%) and mortality (−20%), and increased degree-of-spread specific survival following the introduction of universal health care in 1975 suggest effects of greater access to Pap screening, earlier access to diagnosis and treatment services, and improved effectiveness of treatment. Incidence plateaued during the 1980s, but mortality fell further (−7%) due to an increased proportion of localised cancers (without change to degree-of-spread specific survival). The 1980s mortality reduction was a consequence of earlier diagnosis and/or secondary prevention, not improved treatment effectiveness or reduced incidence. A marked and sustained incidence decline to 2001 (−35%) occurred after the introduction of the NSW Cervical Screening Program in 1992. This was followed 3 years later by a sustained mortality decline (−20%). During the 1990s survival across all degrees of spread remained unchanged and the mortality reduction was due entirely to reduction in incidence.

Conclusions

The substantial reduction of cervical cancer incidence and mortality in NSW over the last 3 decades is associated with important health service interventions that relate to control of cervical cancer, particularly the implementation of a population-based organised cervical screening program.
Literatur
1.
Zurück zum Zitat Sigurdsson, K, Hrafnkelsson, J, Geirsson, G, et al. 1991Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964–1988Gynecol Oncol436470CrossRefPubMed Sigurdsson, K, Hrafnkelsson, J, Geirsson, G,  et al. 1991Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964–1988Gynecol Oncol436470CrossRefPubMed
2.
Zurück zum Zitat Adami, HO, Ponten, J, Sparen, P, et al. 1994Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960–1984Cancer73140147PubMed Adami, HO, Ponten, J, Sparen, P,  et al. 1994Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960–1984Cancer73140147PubMed
3.
Zurück zum Zitat International Agency for Research on Cancer [IARC]1986Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implications for screening policiesBMJ293659664 International Agency for Research on Cancer [IARC]1986Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implications for screening policiesBMJ293659664
4.
Zurück zum Zitat Johannesson, G, Geirsson, G, Day, N 1978The effect of mass screening in Iceland, 1965–74, on the incidence and mortality of cervical carcinomaInt J Cancer21418425PubMed Johannesson, G, Geirsson, G, Day, N 1978The effect of mass screening in Iceland, 1965–74, on the incidence and mortality of cervical carcinomaInt J Cancer21418425PubMed
5.
Zurück zum Zitat Johannesson, G, Geirsson, G, Day, N, et al. 1982Screening for cancer of the uterine cervix in Iceland 1965–1978Acta Obstet Gynecol Scand61199203PubMed Johannesson, G, Geirsson, G, Day, N,  et al. 1982Screening for cancer of the uterine cervix in Iceland 1965–1978Acta Obstet Gynecol Scand61199203PubMed
6.
Zurück zum Zitat Sigurdsson, K 1993Effect of organized screening on the risk of cervical cancer: evaluation of screening activity in Iceland, 1964–1991Int J Cancer54563570PubMed Sigurdsson, K 1993Effect of organized screening on the risk of cervical cancer: evaluation of screening activity in Iceland, 1964–1991Int J Cancer54563570PubMed
7.
Zurück zum Zitat Day, N 1984Effect of cervical cancer screening in ScandinaviaObstet Gynecol63714718PubMed Day, N 1984Effect of cervical cancer screening in ScandinaviaObstet Gynecol63714718PubMed
8.
Zurück zum Zitat Hakama, M, Louhivuori, K 1988A screening programme for cervical cancer that workedCancer Surv7403416PubMed Hakama, M, Louhivuori, K 1988A screening programme for cervical cancer that workedCancer Surv7403416PubMed
9.
Zurück zum Zitat Parkin, DM, Nguyen-Dinh, X, Day, NE 1985The impact of screening on the incidence of cervical cancer in England and WalesBr J Obstet Gynaecol92150157PubMed Parkin, DM, Nguyen-Dinh, X, Day, NE 1985The impact of screening on the incidence of cervical cancer in England and WalesBr J Obstet Gynaecol92150157PubMed
10.
Zurück zum Zitat Macgregor, JE, Campbell, KM, Mann, EMF, Swanson, KY 1994Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive diseaseBMJ30814071411PubMed Macgregor, JE, Campbell, KM, Mann, EMF, Swanson, KY 1994Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive diseaseBMJ30814071411PubMed
11.
Zurück zum Zitat Gibson, L, Spiegelhalter, DJ, Camilleri-Ferrante, C, et al. 1997Trends in invasive cervical cancer incidence in East Anglia from 1971 to 1993J Med Screen44448PubMed Gibson, L, Spiegelhalter, DJ, Camilleri-Ferrante, C,  et al. 1997Trends in invasive cervical cancer incidence in East Anglia from 1971 to 1993J Med Screen44448PubMed
12.
Zurück zum Zitat Quinn, M, Babb, P, Jones, J, Allen, A 1999Effect of screening on incidence of and mortality from cancer of the cervix in England: evaluation based on routinely collected statisticBMJ318904908PubMed Quinn, M, Babb, P, Jones, J, Allen, A 1999Effect of screening on incidence of and mortality from cancer of the cervix in England: evaluation based on routinely collected statisticBMJ318904908PubMed
13.
Zurück zum Zitat Peto, J, Gilham, C, Fletcher, O, Matthews, FE 2004The cervical cancer epidemic that screening has prevented in the UKLancet364249256CrossRefPubMed Peto, J, Gilham, C, Fletcher, O, Matthews, FE 2004The cervical cancer epidemic that screening has prevented in the UKLancet364249256CrossRefPubMed
14.
Zurück zum Zitat Liu, S, Semenciw, R, Probert, A, Mao, Y 2001Cervical cancer in Canada: changing patterns in incidence and mortalityInt J Gynecol Cancer112431CrossRefPubMed Liu, S, Semenciw, R, Probert, A, Mao, Y 2001Cervical cancer in Canada: changing patterns in incidence and mortalityInt J Gynecol Cancer112431CrossRefPubMed
15.
Zurück zum Zitat Laara, E, Day, NE, Hakama, M 1987Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmesLancet112471249PubMed Laara, E, Day, NE, Hakama, M 1987Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmesLancet112471249PubMed
16.
Zurück zum Zitat Aareleid, T, Pukkala, E, Thomson, H, et al. 1993Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened populationEur J Cancer29745749CrossRef Aareleid, T, Pukkala, E, Thomson, H,  et al. 1993Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened populationEur J Cancer29745749CrossRef
17.
Zurück zum Zitat Sigurdsson, K 1999The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995Acta Obstet Gynecol Scand78478485PubMed Sigurdsson, K 1999The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995Acta Obstet Gynecol Scand78478485PubMed
18.
Zurück zum Zitat McCredie, M, Coates, MS, Ford, JM 1989Trends in invasive cancer of the cervix uteri in New South Wales, 1973–1982Aust NZ J Obstet Gynaecol29335339 McCredie, M, Coates, MS, Ford, JM 1989Trends in invasive cancer of the cervix uteri in New South Wales, 1973–1982Aust NZ J Obstet Gynaecol29335339
19.
Zurück zum Zitat McCredie, M, Coates, M, Churches, T 1990Cancer of the Cervix Uteri: New South Wales, Australian Capital Territory 1972–1987Cancer Epidemiology Research Unit and NSW Central Cancer Registry, NSW Cancer CouncilSydney McCredie, M, Coates, M, Churches, T 1990Cancer of the Cervix Uteri: New South Wales, Australian Capital Territory 1972–1987Cancer Epidemiology Research Unit and NSW Central Cancer Registry, NSW Cancer CouncilSydney
20.
Zurück zum Zitat Kricker, A, Bell, J, Coates, M, Taylor, R, Armstrong, B 1996Cancer of the Cervix in NSW 1972 to 1992Cancer Epidemiology Research Unit and NSW Central Cancer Registry, NSW Cancer CouncilSydney Kricker, A, Bell, J, Coates, M, Taylor, R, Armstrong, B 1996Cancer of the Cervix in NSW 1972 to 1992Cancer Epidemiology Research Unit and NSW Central Cancer Registry, NSW Cancer CouncilSydney
21.
Zurück zum Zitat Taylor, R, Bell, J, Coates, M, Churches, T, Wain, G 1996Cervical cancer in New South Wales women: five-year survival, 1972 to 1991ANZ J Pub Health20413420 Taylor, R, Bell, J, Coates, M, Churches, T, Wain, G 1996Cervical cancer in New South Wales women: five-year survival, 1972 to 1991ANZ J Pub Health20413420
22.
Zurück zum Zitat Australian Institute of Health and Welfare [AIHW] (1998) Breast and cervical cancer screening in Australia 1996–1997. AIHW Cat. No. CAN 3 (Cancer Series Number 8). AIHW Canberra Australian Institute of Health and Welfare [AIHW] (1998) Breast and cervical cancer screening in Australia 1996–1997. AIHW Cat. No. CAN 3 (Cancer Series Number 8). AIHW Canberra
23.
Zurück zum Zitat New South Wales Cervical Screening Program and NSW Pap Test Register [NSW CSP/PTR] (1999) Cervical cancer screening in New South Wales: First Annual Statistical report 1997. NSW Health Department, Sydney. http://www.csp.nsw.gov.au New South Wales Cervical Screening Program and NSW Pap Test Register [NSW CSP/PTR] (1999) Cervical cancer screening in New South Wales: First Annual Statistical report 1997. NSW Health Department, Sydney. http://​www.​csp.​nsw.​gov.​au
24.
Zurück zum Zitat Coates M, et al. (1992–1998) Cancer in NSW, Incidence and Mortality [1990–1995, annual reports]. NSW Central Cancer Registry and Cancer Control Information Centre, NSW Cancer Council and NSW Health Department Coates M, et al. (1992–1998) Cancer in NSW, Incidence and Mortality [1990–1995, annual reports]. NSW Central Cancer Registry and Cancer Control Information Centre, NSW Cancer Council and NSW Health Department
25.
Zurück zum Zitat Tracey E, et al. (2003) Cancer in NSW, Incidence and Mortality 2001 [2001 annual report]. NSW Central Cancer Registry, Cancer Research and Registers Division; NSW Cancer Council; and NSW Health Department Tracey E, et al. (2003) Cancer in NSW, Incidence and Mortality 2001 [2001 annual report]. NSW Central Cancer Registry, Cancer Research and Registers Division; NSW Cancer Council; and NSW Health Department
26.
Zurück zum Zitat Taylor, R, Morrell, S, Mamoon, H, Wain, G 2001The effect of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohortJ Epi Com Hlth55782788 Taylor, R, Morrell, S, Mamoon, H, Wain, G 2001The effect of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohortJ Epi Com Hlth55782788
27.
Zurück zum Zitat Muir, C, Waterhouse, J, Mack, T, et al. 1987Cancer Incidence in Five ContinentsInternational Agency for Research on CancerLyon45IARC Publication No 88. Muir, C, Waterhouse, J, Mack, T,  et al. 1987Cancer Incidence in Five ContinentsInternational Agency for Research on CancerLyon45IARC Publication No 88.
28.
Zurück zum Zitat Armitage, P, Berry, G 1994Statistical Methods in Medical Research3Blackwell Scientific PublicationsOxford Armitage, P, Berry, G 1994Statistical Methods in Medical Research3Blackwell Scientific PublicationsOxford
29.
Zurück zum Zitat Yu, XQ, O'Connell, DL, Gibberd, RW, Smith, DP, Armstrong, BK 2003Cancer Survival, Incidence and Mortality by Area Health Service in NSW 1994–2000NSW Cancer CouncilSydney Yu, XQ, O'Connell, DL, Gibberd, RW, Smith, DP, Armstrong, BK 2003Cancer Survival, Incidence and Mortality by Area Health Service in NSW 1994–2000NSW Cancer CouncilSydney
30.
Zurück zum Zitat New South Wales Cervical Screening Program and NSW Pap Test Register [NSW CSP/PTR] (2003) Cervical cancer screening in New South Wales: Annual Statistical report 2002. NSW Health Department, Sydney. http://www.csp.nsw.gov.au New South Wales Cervical Screening Program and NSW Pap Test Register [NSW CSP/PTR] (2003) Cervical cancer screening in New South Wales: Annual Statistical report 2002. NSW Health Department, Sydney. http://​www.​csp.​nsw.​gov.​au
Metadaten
Titel
Decline in Cervical Cancer Incidence and Mortality in New South Wales in Relation to Control Activities (Australia)
verfasst von
Richard Taylor
Stephen Morrell
Hassan Mamoon
Gerard Wain
Jayne Ross
Publikationsdatum
01.04.2006
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 3/2006
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0515-z

Weitere Artikel der Ausgabe 3/2006

Cancer Causes & Control 3/2006 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.